SYSTEMIC MASTOCYTOSES, INDOLENT

Clinical trials for SYSTEMIC MASTOCYTOSES, INDOLENT explained in plain language.

Never miss a new study

Get alerted when new SYSTEMIC MASTOCYTOSES, INDOLENT trials appear

Sign up with your email to follow new studies for SYSTEMIC MASTOCYTOSES, INDOLENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for mastocytosis patients through expanded drug access

Disease control AVAILABLE

This program provides access to the investigational drug bezuclastinib for adults with systemic mastocytosis, a rare disorder where too many mast cells build up in the body. It is for patients whose current treatments are not working well or who have no other good treatment optio…

Matched conditions: SYSTEMIC MASTOCYTOSES, INDOLENT

Sponsor: Cogent Biosciences, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

SYSTEMIC MASTOCYTOSES, INDOLENT

Get alerted when new SYSTEMIC MASTOCYTOSES, INDOLENT trials appear

New hope for mastocytosis patients through expanded drug access